Caricamento...
The prognostic value of a Methylome-based Malignancy Density Scoring System to predict recurrence risk in early-stage Lung Adenocarcinoma
Current NCCN guidelines do not recommend the use of adjuvant chemotherapy for stage IA lung adenocarcinoma patients with R0 surgery. However, 25% to 40% of patients with stage IA disease experience recurrence. Stratifying patients according to the recurrence risk may tailor adjuvant therapy and surv...
Autori principali: | , , , , , , , , , , , , , , , , , , |
---|---|
Natura: | Online Articolo testo |
Lingua: | English |
Pubblicazione: |
Ivyspring International Publisher
2020
|
Soggetti: | |
Accesso online: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359091/ https://www.ncbi.nlm.nih.gov/pubmed/32685009 http://dx.doi.org/10.7150/thno.44229 |